Associate Professor of Surgery, Massachusetts General Hospital
Urology
Dr. Aria F. Olumi, MD
|
|
Give Review
Aria Olumi works in the field of Urology. He graduated from Keck School of Medicine of USC. Keck School of Medicine of USC has a rank of 31 in research and a 72 in primary care He received 4 awards: "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer" and "Fellow (FACS)". Aria Olumi is a published physician. He has 41 papers published. The most current publication "DNA Methyl Transferase 1 Reduces Expression of SRD5A2 in the Aging Adult Prostate." He is registered with Medicare.
Publications
- DNA Methyl Transferase 1 Reduces Expression of SRD5A2 in the Aging Adult Prostate.
- Clinical features of leiomyosarcoma of the urinary Bladder: Analysis of 183 cases.
- 5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.
- Personalized Medicine for Management of Benign Prostatic Hyperplasia.
- Medical Oncology Consultation and Minimization of Overtreatment in Men With Low-Risk Prostate Cancer.
- Prognostic significance of indeterminate lung nodules in Renal cell carcinoma.
- Primary spermatic cord tumors: Disease characteristics, prognostic factors, and treatment outcomes.
- Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer.
- Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the Bladder.
- Metformin decreases glucose oxidation and increases the dependency of prostate Cancer cells on reductive glutamine metabolism.
- In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation.
- Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer.
- A Close Surgical Margin After Radical Prostatectomy is an Independent Predictor of Recurrence.
- Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes.
- Impact on the clinical outcome of prostate Cancer by the 2005 international society of urological pathology modified Gleason grading system.
- Smaller Prostate gland size and older age predict Gleason score upgrading.
- Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
- Men With Organ-confined Prostate Cancer and Positive Surgical Margins Develop Biochemical Failure at a Similar Rate to Men With Extracapsular Extension.
- Reduced levels of 5-α reductase 2 in adult Prostate tissue and implications for BPH therapy.
- Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate Cancer cells.
- Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse Prostate model.
- The hybrid of basic science and clinical training for the urologic oncologist: Necessity or waste?
- MR imaging of Renal masses: correlation with findings at surgery and pathologic analysis.
- Overcoming resistance to trail-induced apoptosis in prostate Cancer by regulation of c-FLIP.
- Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate Cancer cells.
- Novel targeted pro-apoptotic agents for the treatment of prostate Cancer.
- pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2.
- Stromally expressed c-Jun regulates proliferation of Prostate epithelial cells.
- c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate Cancer cells.
- Hypoxia-inducible factor linked to differential kidney Cancer risk seen with type 2A and type 2B VHL mutations.
- Surgical management of scrotal lymphedema using local flaps.
- MG-132 sensitizes TRAIL-resistant prostate Cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).
- Low age adjusted free testosterone levels correlate with poorly differentiated prostate Cancer.
- Urothelial mucosal malformation: a rare cause for ureteropelvic junction obstruction.
- Expression of transforming growth factor-beta 1 and growth in soft agar differentiate Prostate carcinoma-associated fibroblasts from normal Prostate fibroblasts.
- Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in pro...
- Self-retraction clamp for dissection of the posterior prostatic fossa during radical retropubic Prostatectomy.
- Percent of cores positive for Cancer is a better preoperative predictor of Cancer recurrence after radical prostatectomy than prostate specific antigen.
- Extended Prostate needle biopsy improves concordance of Gleason grading between Prostate needle biopsy and radical Prostatectomy.
- The relationship of prostate gland volume to extended needle biopsy on prostate Cancer detection.
Schools
University Of California Los Angeles School Of Medicine
Brigham and Women39s Hospital
Harvard Program
University Of Calif San Francisco
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystotomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- View All
Conditions Treated
- Bladder Atony
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Network Health
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
Brigham and Women's Hospital -
UCSF -
Keck School of Medicine of USC
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1558315184 | |
| NPPES Provider LastName | OLUMI | |
| NPPES Provider FirstName | ARIA | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Urology | |
| Total Claim Count | 336.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558315184 |
| Last Name Of The Provider | OLUMI |
| First Name Of The Provider | ARIA |
| View All |
Similar Doctors
|
|
Dr. Yahir A. Santiago-Lastra, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramdev Konijeti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alejandro Sanchez, MD |
|
|
Dr. Anjali M. Ganatra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gennaro A. Carpinito, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ricardo Munarriz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|